01. Executive Summary 02. Introduction 03. Market Coverage Business Overview Product Offerings 04. Market Landscape 04.1 Market Size and Forecast 04.2 Market Segmentation 04.3 Five Forces Analysis 05. Key Leading Countries Japan China India 06. Vendor Landscape 07. Buying Criteria 08. Market Growth Drivers 09. Drivers and their Impact 10. Market Challenges 11. Impact of Drivers and Challenges 12. Market Trends 13. Key Vendor Analysis 13.1 Johnson & Johnson Business Overview Key Information SWOT Analysis 13.2 GlaxoSmithKline plc Business Overview Key Information SWOT Analysis 13.3 Novartis International AG Business Overview Key Information SWOT Analysis 13.4 Bayer HealthCare AG Business Overview Key Information SWOT Analysis 14. Other Reports in this Series List of Exhibits: Exhibit 1: Over-the-counter Pharmaceuticals Market in the APAC Region 2012–2016 (US$ billion) Exhibit 2: Over-the-counter Pharmaceuticals Market in the APAC Region Segmentation Exhibit 3: Over-the-counter Pharmaceuticals Market in the APAC Region Segmentation 2012 Exhibit 4: Over-the-counter Pharmaceuticals Market in the APAC Region by Vendor Segmentation 2012 Exhibit 5: Business Segmentation of Johnson & Johnson Exhibit 6: Business Segmentation of GlaxoSmithKline plc Exhibit 7: Business Segmentation of Novartis International AG Exhibit 8: Business Segmentation of Bayer HealthCare AG

Johnson & Johnson, GlaxoSmithKline plc, Novartis International AG, Bayer Healthcare AG., Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH, Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Eisai Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., and Schering-Plough Corp., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., Cipla Ltd.